About
Technology
Issues
FAQ
Links
Official Page
Nivolumab (NIVO) + ipilimumab (IPI) combination therapy in patients (pts) with advanced hepatocellular carcinoma (aHCC): Results from CheckMate 040.
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.